Douglas Tsao
Stock Analyst at HC Wainwright & Co.
(2.15)
# 2,781
Out of 4,876 analysts
510
Total ratings
35.59%
Success rate
-3.13%
Average return
Main Sectors:
Stocks Rated by Douglas Tsao
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ROIV Roivant Sciences | Reiterates: Buy | $18 | $11.60 | +55.17% | 20 | Jun 18, 2025 | |
| SAGE Sage Therapeutics | Reiterates: Neutral | $12 | $9.28 | +29.31% | 23 | Jun 17, 2025 | |
| IRON Disc Medicine | Reiterates: Buy | $118 | $54.13 | +117.99% | 15 | Jun 17, 2025 | |
| CABA Cabaletta Bio | Reiterates: Buy | $25 | $1.70 | +1,370.59% | 26 | Jun 11, 2025 | |
| ARGX argenx SE | Reiterates: Buy | $720 | $560.04 | +28.56% | 38 | Jun 11, 2025 | |
| PTGX Protagonist Therapeutics | Reiterates: Buy | $80 | $55.22 | +44.89% | 33 | Jun 3, 2025 | |
| XENE Xenon Pharmaceuticals | Reiterates: Buy | $53 | $32.20 | +64.60% | 5 | May 13, 2025 | |
| PRAX Praxis Precision Medicines | Reiterates: Buy | $105 | $44.26 | +137.23% | 23 | May 1, 2025 | |
| CHRS Coherus Oncology | Reiterates: Buy | $7 | $0.73 | +855.50% | 25 | Apr 29, 2025 | |
| RZLT Rezolute | Reiterates: Buy | $14 | $4.31 | +224.83% | 17 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $34 | $14.55 | +133.68% | 16 | Apr 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $27 | $9.31 | +190.01% | 27 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $19 | $14.40 | +31.94% | 4 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $12 | $2.63 | +356.27% | 17 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $18 | $3.98 | +352.26% | 14 | Mar 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $51 | $16.39 | +211.17% | 22 | Mar 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $18 | $0.80 | +2,151.69% | 7 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $54 | $14.74 | +266.35% | 14 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $57 | $18.40 | +209.78% | 26 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $10.73 | +39.79% | 15 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $5 | $1.80 | +177.78% | 14 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $3 | $1.75 | +71.43% | 16 | Feb 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $46 | $28.83 | +59.56% | 23 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $81 | $29.99 | +170.09% | 23 | Jan 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 | $4.22 | +89.80% | 9 | Nov 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $360 | $0.76 | +47,094.55% | 8 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $10 | $1.17 | +754.70% | 5 | Jun 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $23 → $10 | $29.64 | -66.26% | 7 | Dec 9, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $168 → $182 | $146.75 | +24.02% | 4 | Feb 20, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $19 | $7.00 | +167.86% | 2 | Jan 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $25 → $18 | $25.12 | -28.34% | 3 | Aug 29, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Underweight | $8 | $16.56 | -51.69% | 7 | Jun 11, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $52 | $23.60 | +120.34% | 2 | Jun 11, 2019 |
Roivant Sciences
Jun 18, 2025
Reiterates: Buy
Price Target: $18
Current: $11.60
Upside: +55.17%
Sage Therapeutics
Jun 17, 2025
Reiterates: Neutral
Price Target: $12
Current: $9.28
Upside: +29.31%
Disc Medicine
Jun 17, 2025
Reiterates: Buy
Price Target: $118
Current: $54.13
Upside: +117.99%
Cabaletta Bio
Jun 11, 2025
Reiterates: Buy
Price Target: $25
Current: $1.70
Upside: +1,370.59%
argenx SE
Jun 11, 2025
Reiterates: Buy
Price Target: $720
Current: $560.04
Upside: +28.56%
Protagonist Therapeutics
Jun 3, 2025
Reiterates: Buy
Price Target: $80
Current: $55.22
Upside: +44.89%
Xenon Pharmaceuticals
May 13, 2025
Reiterates: Buy
Price Target: $53
Current: $32.20
Upside: +64.60%
Praxis Precision Medicines
May 1, 2025
Reiterates: Buy
Price Target: $105
Current: $44.26
Upside: +137.23%
Coherus Oncology
Apr 29, 2025
Reiterates: Buy
Price Target: $7
Current: $0.73
Upside: +855.50%
Rezolute
Apr 28, 2025
Reiterates: Buy
Price Target: $14
Current: $4.31
Upside: +224.83%
Apr 23, 2025
Reiterates: Buy
Price Target: $34
Current: $14.55
Upside: +133.68%
Apr 10, 2025
Reiterates: Buy
Price Target: $27
Current: $9.31
Upside: +190.01%
Apr 3, 2025
Reiterates: Buy
Price Target: $19
Current: $14.40
Upside: +31.94%
Apr 1, 2025
Reiterates: Buy
Price Target: $12
Current: $2.63
Upside: +356.27%
Mar 20, 2025
Reiterates: Buy
Price Target: $18
Current: $3.98
Upside: +352.26%
Mar 19, 2025
Reiterates: Buy
Price Target: $51
Current: $16.39
Upside: +211.17%
Mar 7, 2025
Reiterates: Buy
Price Target: $18
Current: $0.80
Upside: +2,151.69%
Mar 4, 2025
Reiterates: Buy
Price Target: $54
Current: $14.74
Upside: +266.35%
Mar 3, 2025
Reiterates: Buy
Price Target: $57
Current: $18.40
Upside: +209.78%
Feb 27, 2025
Reiterates: Buy
Price Target: $15
Current: $10.73
Upside: +39.79%
Feb 26, 2025
Reiterates: Neutral
Price Target: $5
Current: $1.80
Upside: +177.78%
Feb 18, 2025
Maintains: Buy
Price Target: $30 → $3
Current: $1.75
Upside: +71.43%
Feb 13, 2025
Reiterates: Neutral
Price Target: $46
Current: $28.83
Upside: +59.56%
Jan 13, 2025
Reiterates: Buy
Price Target: $81
Current: $29.99
Upside: +170.09%
Nov 7, 2024
Reiterates: Buy
Price Target: $8
Current: $4.22
Upside: +89.80%
Oct 1, 2024
Reiterates: Buy
Price Target: $360
Current: $0.76
Upside: +47,094.55%
Jun 7, 2022
Downgrades: Neutral
Price Target: $10
Current: $1.17
Upside: +754.70%
Dec 9, 2021
Maintains: Neutral
Price Target: $23 → $10
Current: $29.64
Upside: -66.26%
Feb 20, 2020
Maintains: Equal-Weight
Price Target: $168 → $182
Current: $146.75
Upside: +24.02%
Jan 23, 2020
Downgrades: Neutral
Price Target: $19
Current: $7.00
Upside: +167.86%
Aug 29, 2019
Maintains: Underweight
Price Target: $25 → $18
Current: $25.12
Upside: -28.34%
Jun 11, 2019
Initiates: Underweight
Price Target: $8
Current: $16.56
Upside: -51.69%
Jun 11, 2019
Initiates: Overweight
Price Target: $52
Current: $23.60
Upside: +120.34%